120 related articles for article (PubMed ID: 37350418)
1. Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
López-González E; Rodriguez-Jiménez A; Gómez-Salgado J; Daza-Manzano C; Rojas-Luna JA; Alvarez RM
Int J Gynaecol Obstet; 2023 Dec; 163(3):840-846. PubMed ID: 37350418
[TBL] [Abstract][Full Text] [Related]
2. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
[TBL] [Abstract][Full Text] [Related]
3. Values of tumor volume on magnetic resonance imaging for a surgical approach to endometrial cancer.
López-González E; Rodríguez-Jiménez A; Rojas-Luna JA; Daza-Manzano C; Gómez-Salgado J
Cancer Med; 2023 Sep; 12(17):17671-17678. PubMed ID: 37602828
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer?
Sahin H; Sarioglu FC; Bagci M; Karadeniz T; Uluer H; Sanci M
Int J Gynecol Cancer; 2018 May; 28(4):666-674. PubMed ID: 29697491
[TBL] [Abstract][Full Text] [Related]
5. Tumoral volume measured preoperatively by magnetic resonance imaging is related to survival in endometrial cancer.
Coronado PJ; Santiago-López J; Santiago-García J; Méndez R; Fasero M; Herraiz MA
Radiol Oncol; 2021 Jan; 55(1):35-41. PubMed ID: 33885237
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.
Yan B; Liang X; Zhao T; Niu C; Ding C; Liu W
Eur Radiol; 2019 Feb; 29(2):838-848. PubMed ID: 30039225
[TBL] [Abstract][Full Text] [Related]
7. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
[TBL] [Abstract][Full Text] [Related]
8. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
Fan Z; Sun X; Han X; Sun C; Huang D
Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
[TBL] [Abstract][Full Text] [Related]
9. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
10. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
13. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
14. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
15. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
17. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
